The short version
Only one company currently supplies this market — there is no backup if it stumbles.
The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.
Homwis Eczema Relief
Homwis Eczema Relief · MELALEUCA ALTERNIFOLIA LEAF 1 g/100g · Soap · Topical · Shenzhen Ishan Technology Co., Ltd
NDC 73076-0502-02 · 100 g in 1 BOX · UNAPPROVED DRUG OTHER · View full market →
Medicare Part D
No Medicare Part D plan in CMS's quarterly files lists this product. That usually means it is discontinued, a repackager's listing, or a product no plan has added to its formulary.
How Part D pricing works →NADAC price per unit
No NADAC pricing on file for this NDC — NADAC covers drugs dispensed by retail community pharmacies.
Supply fragility
Not scored — fragility is computed for NADAC-priced NDCs.
Regulatory
- Application
- —
- TE code
- —
- Approval date
- —
- Patents / exclusivity
- —
Shortage history
No FDA shortage reports for this drug or its presentations.
Recalls (this NDC)
No enforcement reports list this package NDC.
Manufacturers of Homwis Eczema Relief (Soap)
| Labeler | Strength | First seen | Last seen |
|---|---|---|---|
| Shenzhen Ishan Technology Co., Ltd | MELALEUCA ALTERNIFOLIA LEAF 1 g/100g | Jul 15, 2026 | Sep 2, 2026 |
Roster from daily NDC Directory diffs — first/last seen dates start July 2026.
Cite this page
DrugDashboards, "Homwis Eczema Relief — NDC 73076-0502-02," retrieved September 3, 2026, https://drugdashboards.com/drug/73076050202.
Free to cite with attribution — see how the data is put together.